|
|
 |
|
Viewing report
|
|
|
|
Strategic Alliances in World Pharma and Biotech Markets
Energy Business Reports, May 2008, Pages: 52
Executive Summary 6
Introduction to the Synergy between Pharma & Biotech Industries 7
Overview 7
Brief History 7
Thaliomid Predicament - Impact in the Form of Industry Consolidation 9
Emergence of Genentech and Evolution of Industry-wide Alliances 10
Introduction to the Biotechnology Industry and Drug Development 14
Defining Biotechnology 14
History of Biotechnology 14
Applications of Biotechnology 15
What is Drug Development? 17
Importance of the Development of New Chemical Entity to Drug Development 17
Cost of the Drug Development Process 18
Biotechnology and Drug Development – A Symbiotic Relationship 19
Biotech/Pharma Industries and Network Economics, Competency and Market Structure 21
Overview 21
Role of Genomics 21
Role of Pharma-Biotech Alliances – Present Day Situation 24
Increasing Collaborative EfforExecutive Summary 6
Introduction to the Synergy between Pharma & Biotech Industries 7
Overview 7
Brief History 7
Thaliomid Predicament - Impact in the Form of Industry Consolidation 9
Emergence of Genentech and Evolution of Industry-wide Alliances 10
Introduction to the Biotechnology Industry and Drug Development 14
Defining Biotechnology 14
History of Biotechnology 14
Applications of Biotechnology 15
What is Drug Development? 17
Importance of the Development of New Chemical Entity to Drug Development 17
Cost of the Drug Development Process 18
Biotechnology and Drug Development – A Symbiotic Relationship 19
Biotech/Pharma Industries and Network Economics, Competency and Market Structure 21
Overview 21
Role of Genomics 21
Role of Pharma-Biotech Alliances – Present Day Situation 24
Increasing Collaborative Efforts in Global Pharma and Biotech Markets 27
Major Players in the Global Biotech Industry 29
Amgen 29
Takeda 29
Oxford Genome Sciences 30
Dompé Biotec 30
Daiichi Sankyo 30
Cytokinetics Incorporated 31
Fresenius Medical Care 31
Genentech 31
Altor BioScience 32
BioInvent AB 32
Abbott Laboratories 32
Genzyme 33
Isis Pharmaceuticals, Inc. 33
Moffitt Cancer Center 33
BioMarin Pharmaceutical Inc 34
Fovea Pharmaceuticals 34
Gilead Sciences 34
Bristol-Myers Squibb Company 35
LG Life Sciences 35
Serono 35
Flamel Technologies 36
Idera Pharmaceuticals 36
ZymoGenetics Inc. 36
Archemix 36
Major Players in the Global Pharma Industry 38
Johnson & Johnson 38
Molecular Partners 38
Galapagos 38
Melior Discovery Inc 39
Pfizer 39
Scil Technology GmbH 39
Taisho Pharmaceutical 39
Tacere Therapeutics Inc 40
Adolor Corp 40
Bristol-Myers Squibb Co 40
GlaxoSmithKline 41
Amira Pharmaceuticals 41
GeneCo 41
Santaris Pharma 42
Galapagos 42
Novartis 42
Mitsubishi Tanabe Pharma 42
MorphoSys 43
Intercell 43
Sanofi-Aventis 43
Statens Serum Institut of Denmark (SSI) 44
Dyax Corp. 44
Crucell N.V. 44
Regeneron Pharmaceuticals Inc. 45
Acambis Plc 45
Glossary 46
ts in Global Pharma and Biotech Markets 27
Major Players in the Global Biotech Industry 29
Amgen 29
Takeda 29
Oxford Genome Sciences 30
Dompé Biotec 30
Daiichi Sankyo 30
Cytokinetics Incorporated 31
Fresenius Medical Care 31
Genentech 31
Altor BioScience 32
BioInvent AB 32
Abbott Laboratories 32
Genzyme 33
Isis Pharmaceuticals, Inc. 33
Moffitt Cancer Center 33
BioMarin Pharmaceutical Inc 34
Fovea Pharmaceuticals 34
Gilead Sciences 34
Bristol-Myers Squibb Company 35
LG Life Sciences 35
Serono 35
Flamel Technologies 36
Idera Pharmaceuticals 36
ZymoGenetics Inc. 36
Archemix 36
Major Players in the Global Pharma Industry 38
Johnson & Johnson 38
Molecular Partners 38
Galapagos 38
Melior Discovery Inc 39
Pfizer 39
Scil Technology GmbH 39
Taisho Pharmaceutical 39
Tacere Therapeutics Inc 40
Adolor Corp 40
Bristol-Myers Squibb Co 40
GlaxoSmithKline 41
Amira Pharmaceuticals 41
GeneCo 41
Santaris Pharma 42
Galapagos 42
Novartis 42
Mitsubishi Tanabe Pharma 42
MorphoSys. 43
Intercell 43
Sanofi-Aventis 43
Statens Serum Institut of Denmark (SSI) 44
Dyax Corp. 44
Crucell N.V. 44
Regeneron Pharmaceuticals Inc. 45
Acambis Plc 45
Glossary 46
Customers who bought this item also bought
Drug Delivery Partnering Agreements in Pharma and Biotech
Biotech 2009-Life Sciences: Navigating the Sea Change
The Pharmaceutical Company Outlook to 2012: Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
Biotechnology in India
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Pharmaceuticals - Global Outlook
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Bristol-Myers Squibb Co.: PharmaVitae Profile
China Pharma Outsourcing Market By 2015
Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011
The Pharmaceutical Company Outlook to 2011: Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
Hospital Antibiotics Pipeline Analysis: Big Pharma's Retreat Creates Opportunities for Biotech
|
|
|
|
